ESC 365 - SGLT2 inhibition: a new horizon in type-2 diabetes

ACVC Premium Access

SGLT2 inhibition: a new horizon in type-2 diabetes

Session: Risk reduction after acute coronary syndrome

Topic: Miscellaneous

Speaker: Professor D. Grobbee (Utrecht, NL)

Event: Acute Cardiovascular Care 2016

Congress Presentation

Add to my library

About the speaker

Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))

40 presentations

11 followers

3 more presentations in this session

Thrombosis and anti thrombotics – lessons from recent RCTs.

Speaker: Professor P. Clemmensen (Hamburg, DE)

Is there still a role for beta blockers in patients with preserved LV function?

Speaker: Professor D. Zahger (Beer Sheva, IL)

The role of non invasive imaging for risk assessment.

Speaker: Professor N. Cardim (Lisbon, PT)

Access the full session

Risk reduction after acute coronary syndrome

Speakers: Professor D. Grobbee, Professor P. Clemmensen, Professor D. Zahger, Professor N. Cardim

About the event

Acute Cardiovascular Care 2016

15 October - 17 October 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources